HIV Drug Resistance in Pregnant Women in Tanzania
Author Information
Author(s): Nyombi Balthazar M, Holm-Hansen Carol, Kristiansen Knut I, Bjune Gunnar, Müller Fredrik
Primary Institution: Kilimanjaro Christian Medical College, Moshi, Tanzania
Hypothesis
What is the prevalence of mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Tanzania?
Conclusion
The baseline prevalence of primary mutations associated with antiretroviral drug resistance among treatment-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions is low.
Supporting Evidence
- Primary mutations associated with NRTI resistance were detected among 3% of treatment-naïve strains.
- Primary mutations associated with NNRTI resistance were found in 4% of treatment-naïve strains.
- None of the primary mutations associated with PI resistance was found.
Takeaway
The study found that very few pregnant women in Tanzania have mutations that make HIV drugs less effective, which is good news for their treatment.
Methodology
The study analyzed HIV-1 pol gene sequences from 246 pregnant women, comparing those who were treatment-naïve and those who had received a single dose of Nevirapine.
Potential Biases
Potential bias due to reliance on self-reported information regarding drug exposure.
Limitations
Self-reported drug exposure may lead to under- or over-reporting, affecting the reliability of the findings.
Participant Demographics
The study included 246 HIV-1 infected pregnant women from Kagera and Kilimanjaro regions.
Statistical Information
P-Value
p = 0.032
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website